Baker Brothers Advisors - AEVI GENOMIC MEDICINE INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AEVI GENOMIC MEDICINE INC
ValueSharesWeighting
Q4 2018$2,765,000
-43.1%
3,950,4190.0%0.02%
-28.1%
Q3 2018$4,859,000
+8.0%
3,950,419
-2.6%
0.03%
-5.9%
Q2 2018$4,501,000
-44.8%
4,055,1420.0%0.03%
-50.7%
Q1 2018$8,151,000
+67.5%
4,055,1420.0%0.07%
+64.3%
Q4 2017$4,866,000
-15.0%
4,055,142
-10.8%
0.04%
-8.7%
Q3 2017$5,728,000
+166.2%
4,546,426
+181.0%
0.05%
+142.1%
Q2 2017$2,152,000
-28.5%
1,618,0890.0%0.02%
-24.0%
Q1 2017$3,010,000
-34.0%
1,618,089
+83.8%
0.02%
-44.4%
Q4 2016$4,561,000880,5390.04%
Other shareholders
AEVI GENOMIC MEDICINE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 128,000$142,0000.10%
Baker Brothers Advisors 4,055,142$4,501,0000.03%
WEDBUSH SECURITIES INC 209,524$233,0000.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,500,000$6,105,0000.01%
Verity Asset Management, Inc. 11,500$13,0000.01%
OneDigital Investment Advisors LLC 11,437$13,0000.00%
HYMAN CHARLES D 15,143$17,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 120,619$134,0000.00%
Legacy Advisors, LLC 2,450$3,0000.00%
Kavar Capital Partners, LLC 1,500$2,0000.00%
View complete list of AEVI GENOMIC MEDICINE INC shareholders